Piper Jaffray downgrade from overweight to neutral. We can take some comfort in the fact that the last time they did this (July 2016), the price increased 100% over the course of the year :)
Jefferies raised SUPN PT to $51 on 6/28/17
Supernus Pharmaceuticals, Inc. (SUPN) PT Raised to $51.00 at Jefferies Group LLC Posted by Renata Jones on Jul 13th, 2017 // No Comments Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) had its target price hoisted by Jefferies Group LLC from $45.00 to $51.00 in a research note issued to investors on Wednesday, June 28th. Jefferies Group LLC currently has a buy rating on the specialty pharmaceutical company’s stock.
[!] Just updated to now display all possible spread combinations - Option spread traders visit CreditSpreads.io, zero cost live table of mathematically profitable option credit spreads for the coming 4 weeks, sometimes including spreads for SUPN! High-probability option credit spreads supply a strategy to invest with specified risk and the max profit gained up front. CreditSpreads.io targets only the spreads which meet its rigid criteria for risk and profit, and ensures sustained profitability by warning you of any future catalysts that could affect the trade. www.creditspreads.io
Sustainable, high probability, defined risk stock option trading opportunities.
Piper Jaffray downgrade to Neutral with a $46 tag.
Can't find a reason for this pullback
what the hell
Why the pullback? Its just had another upgrade with a target of $49
Looking for another solid quarter and new higher price targets here.
If we are to go off the RSI then you could argue that a pull back next day or so could occur on SUPN before rallying up. check out awe.some.stocks, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
Did anyone hear the brief blurb on Bloomberg radio, Friday afternoon, June 23, about a venture firm being in talks with Supernus regarding a potential buy out?
Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) has been a wonderful, long-term biotech stock, going from 9.00 to 43.00. It formed a wedge, popped out of the wedge, and ran 1.35, or 3%, to 42.75, on 579,086 shares traded on Wednesday. It may get a pullback in this zone, but if it accelerates, I’m looking for 40-50 as the next target. It has 5 days to cover .
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.6 In other words, the correlation coefficient of the other stoc
Stock trading predictive short and long algorithm services for the novice to expert investor.
Mydayis finally approved... ?single-digit? royalty. If GtN is good, should bring in 10 m or so to the bottom line over time...
Do you think this thing is done selling? Showing us a buy signal now on SUPN? check out awe_some_stock_s, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
In the short-term SUPN does not seem to be like a good trade. if you guys have questions you should ask awesome.stock.s. They often respond to my emails which is helpful.
Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) had a very nice session on Wednesday, jumping 2.20, or 6.2%, to 37.60, on 1.15 million shares traded. It’s trending nicely. My near-term target is 39-40, followed by 48-50 eventually.